TEAS Request Reconsideration after FOA

OPTEJET

Eyenovia, Inc.

TEAS Request Reconsideration after FOA

PTO- 1960
Approved for use through 11/30/2023. OMB 0651-0050
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Request for Reconsideration after Final Action


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88923457
LAW OFFICE ASSIGNED LAW OFFICE 112
MARK SECTION
MARK FILE NAME http://uspto.report/TM/88923457/mark.png
LITERAL ELEMENT OPTEJET
STANDARD CHARACTERS NO
USPTO-GENERATED IMAGE NO
GOODS AND/OR SERVICES SECTION (current)
INTERNATIONAL CLASS 010
DESCRIPTION
Medical devices for the diagnosis and treatment of eyes, namely, for diagnosis or treatment of ocular diseases in conditions; ophthalmology medical devices, namely, an ophthalmic spray dispenser; Drug delivery system for pharmaceutical mydriasis, used in the preparation for treatment of ocular diseases in conditions, namely, a dispenser for eye drops, sold without the drugs
FILING BASIS Section 1(a)
        FIRST USE ANYWHERE DATE At least as early as 02/21/2020
        FIRST USE IN COMMERCE DATE At least as early as 02/21/2020
GOODS AND/OR SERVICES SECTION (proposed)
INTERNATIONAL CLASS 010
TRACKED TEXT DESCRIPTION
Medical devices for the diagnosis and treatment of eyes, namely, for diagnosis or treatment of ocular diseases in conditions; ophthalmology medical devices, namely, an ophthalmic spray dispenser; ophthalmology medical devices, namely, an ophthalmic spray dispenser sold empty; drug delivery system for pharmaceutical mydriasis, used in the preparation for treatment of ocular diseases in conditions, namely, a dispenser for eye drops, sold without the drugs
FINAL DESCRIPTION
Medical devices for the diagnosis and treatment of eyes, namely, for diagnosis or treatment of ocular diseases in conditions; ophthalmology medical devices, namely, an ophthalmic spray dispenser sold empty; drug delivery system for pharmaceutical mydriasis, used in the preparation for treatment of ocular diseases in conditions, namely, a dispenser for eye drops, sold without the drugs
FILING BASIS Section 1(a)
       FIRST USE ANYWHERE DATE At least as early as 02/21/2020
       FIRST USE IN COMMERCE DATE At least as early as 02/21/2020
        WEBPAGE URL None Provided
        WEBPAGE DATE OF ACCESS None Provided
CORRESPONDENCE INFORMATION (current)
NAME Karen Won
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE ipdocketingbos@mintz.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) kwon@mintz.com; acromanini@mintz.com
DOCKET/REFERENCE NUMBER 054216-401
CORRESPONDENCE INFORMATION (proposed)
NAME Karen Won
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE ipdocketingbos@mintz.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) kwon@mintz.com; acromanini@mintz.com
DOCKET/REFERENCE NUMBER 054216-401
SIGNATURE SECTION
RESPONSE SIGNATURE /kkw/
SIGNATORY'S NAME Karen Won
SIGNATORY'S POSITION Attorney for Applicant (NY Bar Member)
SIGNATORY'S PHONE NUMBER 2126926704
DATE SIGNED 08/30/2021
ROLE OF AUTHORIZED SIGNATORY Authorized U.S.-Licensed Attorney
SIGNATURE METHOD Sent to third party for signature
CONCURRENT APPEAL NOTICE FILED NO
FILING INFORMATION SECTION
SUBMIT DATE Tue Aug 31 09:59:33 ET 2021
TEAS STAMP USPTO/RFR-XX.XXX.XXX.XXX-
20210831095933282823-8892
3457-781884a261d518d68d57
21f78ffd03af617e627e2597b
634db2238e22c5a2d70d-N/A-
N/A-20210827164016564750



PTO- 1960
Approved for use through 11/30/2023. OMB 0651-0050
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Request for Reconsideration after Final Action


To the Commissioner for Trademarks:

Application serial no. 88923457 OPTEJET (Stylized and/or with Design, see http://tmng-al.uspto.gov /resting2/api/img/8892345 7/large) has been amended as follows:

CLASSIFICATION AND LISTING OF GOODS/SERVICES

Applicant proposes to amend the following:

Current:
Class 010 for Medical devices for the diagnosis and treatment of eyes, namely, for diagnosis or treatment of ocular diseases in conditions; ophthalmology medical devices, namely, an ophthalmic spray dispenser; Drug delivery system for pharmaceutical mydriasis, used in the preparation for treatment of ocular diseases in conditions, namely, a dispenser for eye drops, sold without the drugs
Filing Basis: Section 1(a), Use in Commerce: The applicant is using the mark in commerce, or the applicant's related company or licensee is using the mark in commerce, on or in connection with the identified goods and/or services. 15 U.S.C. Section 1051(a), as amended. The mark was first used at least as early as 02/21/2020 and first used in commerce at least as early as 02/21/2020 , and is now in use in such commerce.


Proposed:

Tracked Text Description: Medical devices for the diagnosis and treatment of eyes, namely, for diagnosis or treatment of ocular diseases in conditions; ophthalmology medical devices, namely, an ophthalmic spray dispenser; ophthalmology medical devices, namely, an ophthalmic spray dispenser sold empty; drug delivery system for pharmaceutical mydriasis, used in the preparation for treatment of ocular diseases in conditions, namely, a dispenser for eye drops, sold without the drugsClass 010 for Medical devices for the diagnosis and treatment of eyes, namely, for diagnosis or treatment of ocular diseases in conditions; ophthalmology medical devices, namely, an ophthalmic spray dispenser sold empty; drug delivery system for pharmaceutical mydriasis, used in the preparation for treatment of ocular diseases in conditions, namely, a dispenser for eye drops, sold without the drugs
Filing Basis: Section 1(a), Use in Commerce: The applicant is using the mark in commerce, or the applicant's related company or licensee is using the mark in commerce, on or in connection with the identified goods and/or services. 15 U.S.C. Section 1051(a), as amended. The mark was first used at least as early as 02/21/2020 and first used in commerce at least as early as 02/21/2020 , and is now in use in such commerce.

Webpage URL: None Provided
Webpage Date of Access: None Provided
Correspondence Information (current):
      Karen Won
      PRIMARY EMAIL FOR CORRESPONDENCE: ipdocketingbos@mintz.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): kwon@mintz.com; acromanini@mintz.com

The docket/reference number is 054216-401.
Correspondence Information (proposed):
      Karen Won
      PRIMARY EMAIL FOR CORRESPONDENCE: ipdocketingbos@mintz.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): kwon@mintz.com; acromanini@mintz.com

The docket/reference number is 054216-401.

Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

SIGNATURE(S)
Request for Reconsideration Signature
Signature: /kkw/     Date: 08/30/2021
Signatory's Name: Karen Won
Signatory's Position: Attorney for Applicant (NY Bar Member)

Signatory's Phone Number: 2126926704 Signature method: Sent to third party for signature

The signatory has confirmed that he/she is a U.S.-licensed attorney who is an active member in good standing of the bar of the highest court of a U.S. state (including the District of Columbia and any U.S. Commonwealth or territory); and he/she is currently the owner's/holder's attorney or an associate thereof; and to the best of his/her knowledge, if prior to his/her appointment another U.S.-licensed attorney not currently associated with his/her company/firm previously represented the owner/holder in this matter: the owner/holder has revoked their power of attorney by a signed revocation or substitute power of attorney with the USPTO; the USPTO has granted that attorney's withdrawal request; the owner/holder has filed a power of attorney appointing him/her in this matter; or the owner's/holder's appointed U.S.-licensed attorney has filed a power of attorney appointing him/her as an associate attorney in this matter.

The applicant is not filing a Notice of Appeal in conjunction with this Request for Reconsideration.

Mailing Address:    Karen Won
   Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C
   
   One Financial Center
   Boston, Massachusetts 02111
Mailing Address:    Karen Won
   Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C
   One Financial Center
   Boston, Massachusetts 02111
        
Serial Number: 88923457
Internet Transmission Date: Tue Aug 31 09:59:33 ET 2021
TEAS Stamp: USPTO/RFR-XX.XXX.XXX.XXX-202108310959332
82823-88923457-781884a261d518d68d5721f78
ffd03af617e627e2597b634db2238e22c5a2d70d
-N/A-N/A-20210827164016564750



uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed